PRPSAP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.837000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.780000E-01
Normal-vs-Stage2
9.508300E-02
Normal-vs-Stage3
4.236300E-02
Normal-vs-Stage4
1.507240E-01
Stage1-vs-Stage2
1.496960E-01
Stage1-vs-Stage3
7.950000E-02
Stage1-vs-Stage4
3.821400E-01
Stage2-vs-Stage3
1.277050E-01
Stage2-vs-Stage4
9.980400E-01
Stage3-vs-Stage4
7.984100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.173200E-01
Normal-vs-AfricanAmerican
3.670000E-01
Normal-vs-Asian
9.936200E-02
Caucasian-vs-AfricanAmerican
6.713200E-01
Caucasian-vs-Asian
4.793200E-01
AfricanAmerican-vs-Asian
2.235400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.969790E-01
Normal-vs-Female
3.961600E-01
Male-vs-Female
4.499000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.638800E-01
Normal-vs-Age(41-60Yrs)
4.088600E-01
Normal-vs-Age(61-80Yrs)
2.321800E-01
Normal-vs-Age(81-100Yrs)
3.623000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.238200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.557000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.541200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.949770E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.504600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.075000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.961800E-02
Normal-vs-Daily Drinker
1.618640E-01
Normal-vs-Weekly Drinker
1.224630E-01
Normal-vs-Occasional Drinker
8.099400E-01
Normal-vs-Social Drinker
4.202600E-01
Non Drinker-vs-Daily Drinker
8.793000E-01
Non Drinker-vs-Weekly Drinker
9.172200E-01
Non Drinker-vs-Occasional Drinker
2.050600E-01
Non Drinker-vs-Social Drinker
5.560600E-01
Daily Drinker-vs-Weekly Drinker
8.411200E-01
Daily Drinker-vs-Occasional Drinker
2.015200E-01
Daily Drinker-vs-Social Drinker
5.069800E-01
Weekly Drinker-vs-Occasional Drinker
2.473000E-01
Weekly Drinker-vs-Social Drinker
6.380800E-01
Occasional Drinker-vs-Social Drinker
5.031400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.615600E-01
Normal-vs-Grade 2
9.629000E-01
Normal-vs-Grade 3
9.455000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.196150E-02
Grade 1-vs-Grade 3
9.397400E-03
Grade 1-vs-Grade 4
5.615600E-01
Grade 2-vs-Grade 3
7.084600E-01
Grade 2-vs-Grade 4
9.629000E-01
Grade 3-vs-Grade 4
9.455000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.183810E-01
Normal-vs-NonDiabetic
3.374600E-01
Diabetic-vs-NonDiabetic
1.813950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.152300E-02
Normal-vs-NoPancreatitis
2.680800E-01
Pancreatitis-vs-NoPancreatitis
1.856800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.504800E-01
Normal-vs-N1
8.140500E-02
N0-vs-N1
5.035800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.878500E-02
Normal-vs-TP53-NonMutant
9.770200E-01
TP53-Mutant-vs-TP53-NonMutant
1.69114999999387E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
